𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The measurement of erythrocyte uroporphyrinogen i synthase in the diagnosis of latent and acute intermittent porphyria

✍ Scribed by David Brocklehurst; Eva A. Wider De Xifra; Alcira Batlle


Publisher
Elsevier Science
Year
1980
Tongue
English
Weight
293 KB
Volume
12
Category
Article
ISSN
0020-711X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Molecular basis of acute intermittent po
✍ Kenneth H. Astrin; Robert J. Desnick πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English

Acute intermittent porphyria (AIP) is an autosomal dominant inborn error of metabolism that results from the half-normal activity of the third enzyme in the heme biosynthetic pathway, hydroxymethylbilane synthase (HMB-synthase). AIP is an ecogenetic condition, with 1ife.threatening acute attacks pre

Erythrocyte uroporphyrinogen synthase ac
✍ Orit Epstein; Meir Lahav; Nili Schoenfeld; Lila Nemesh; Mati Shaklai; Abraham At πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 446 KB πŸ‘ 1 views

Patients with active lymphoproliferative diseases were shown to have high activity of erythrocyte uroporphyrinogen synthetase (URO-S), the enzyme which converts porphobilinogen to uroporphyrinogen. In a few patients examined the lymphocyte URO-S was markedly increased. No correlation was found betwe

Molecular study of the hydroxymethlybila
✍ Anita Gregor; Xiaoye Schneider-Yin; Urszula Szlendak; Albert Wettstein; Agnieszk πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

Acute intermittent porphyria (AIP), an autosomal dominant disorder of heme biosynthesis, is due to mutations in hydroxymethylbilane synthase (HMBS; or porphobilinogen deaminase, PBGD) gene. In this study, we analyzed 20 Polish patients affected by AIP and we were able to characterize seven novel mut

Molecular basis of congenital erythropoi
✍ Weiming Xu; Kenneth H. Astrin; Robert J. Desnick πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 541 KB

Congenital erythropoietic porphyria (CEP) is an autosomal recessive inborn error of metabolism that results from the markedly deficient activity of the fourth enzyme in the heme biosynthetic pathway, uroporphyrinogen 111 synthase (URO-synthase). T o date, 17 mutations have been described including 1